In AML, not otherwise specified subcategories have no prognostic value when classified by NPM1 mutation and CEBPA biallelic mutation status; therefore, acute erythroid leukemia, erythroid/myeloid type has been removed from the category [28,29]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.